Citigroup Downgrades Glaukos (NYSE:GKOS) to Neutral

Glaukos (NYSE:GKOS – Get Free Report) was downgraded by equities research analysts at Citigroup from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, Marketbeat Ratings reports. They currently have a $132.00 price target on the medical instruments supplier’s stock, up from their prior price target of $130.00. Citigroup’s […]

Leave a Reply

Your email address will not be published.

Previous post J.B. Hunt Transport Services (NASDAQ:JBHT) Price Target Lowered to $185.00 at Benchmark
Next post Deutsche Bank Aktiengesellschaft Downgrades 10x Genomics (NASDAQ:TXG) to Hold